- Home
- CAST vs FENC Comparison
CAST vs FENC Comparison
Compare CAST & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.45
HOLD
Current Price
$9.64
Company Overview
Basic Information| Metric | CAST | FENC |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.9M | 230.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | CAST | FENC |
|---|---|---|
| Price | $1.45 | $9.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $6.00 | ★ $14.50 |
| AVG Volume (30 Days) | ★ 763.5K | 219.6K |
| Earning Date | 06-26-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $44,642,000.00 |
| Revenue This Year | N/A | $65.12 |
| Revenue Next Year | N/A | $41.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.36 | $5.65 |
| 52 Week High | $4.90 | $9.92 |
Technical Indicators
Market Signals| Indicator | CAST | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 76.69 |
| Support Level | N/A | $7.49 |
| Resistance Level | $4.83 | $9.92 |
| Average True Range (ATR) | 0.32 | 0.57 |
| MACD | -0.02 | 0.30 |
| Stochastic Oscillator | 5.37 | 87.13 |
Price Performance
Historical Comparison CAST
FENC
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.